BMY icon

Bristol-Myers Squibb
BMY

Upgrade to unlock
Buy
Hold
Sell

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$57
1% downside
High target

9 analyst ratings

positive
4  neutral
44%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Leerink Partners
Leerink Partners
David Risinger
100% 1-yr BMY win rate
13 Jan ‘26 yesterday
Scotiabank
Scotiabank
Louise Chen
9 Jan ‘26 5 days ago
Citigroup
Citigroup
Andrew Baum
7 Jan ‘26 7 days ago
UBS
UBS
Michael Yee
100% 1-yr BMY win rate
7 Jan ‘26 7 days ago
BofA Securities
BofA Securities
Tim Anderson
100% 1-yr BMY win rate
15 Dec ‘25 1 month ago
Morgan Stanley
Morgan Stanley
Terence Flynn
0% 1-yr BMY win rate
12 Dec ‘25 1 month ago
Guggenheim
Guggenheim
Seamus Fernandez
100% 1-yr BMY win rate
12 Dec ‘25 1 month ago
Wells Fargo
Wells Fargo
Mohit Bansal
10 Dec ‘25 1 month ago
Goldman Sachs
Goldman Sachs
Asad Haider
2 Dec ‘25 1 month ago